Latest Insider Transactions at Evolus, Inc. (EOLS)
This section provides a real-time view of insider transactions for Evolus, Inc. (EOLS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Evolus, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Evolus, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2022
|
Medytox Inc. |
SELL
Open market or private sale
|
Direct |
20,700
-0.28%
|
$207,000
$10.53 P/Share
|
|
Sep 08
2022
|
Medytox Inc. |
SELL
Open market or private sale
|
Direct |
15,300
-0.21%
|
$153,000
$10.39 P/Share
|
|
Sep 07
2022
|
Robert Hayman Director |
BUY
Open market or private purchase
|
Direct |
4,967
+11.08%
|
$49,670
$10.05 P/Share
|
|
Sep 06
2022
|
Simone Blank Director |
BUY
Open market or private purchase
|
Direct |
20,000
+26.71%
|
$180,000
$9.24 P/Share
|
|
Sep 06
2022
|
Peter C Farrell Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$90,000
$9.1 P/Share
|
|
Sep 05
2022
|
Sandra Beaver Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,443
+50.0%
|
-
|
|
Aug 01
2022
|
Medytox Inc. |
SELL
Open market or private sale
|
Direct |
26,000
-0.35%
|
$338,000
$13.28 P/Share
|
|
May 18
2022
|
Lauren P Silvernail Officer |
SELL
Open market or private sale
|
Direct |
52,015
-26.87%
|
$624,180
$12.42 P/Share
|
|
May 17
2022
|
Lauren P Silvernail Officer |
SELL
Open market or private sale
|
Direct |
16,189
-7.72%
|
$210,457
$13.92 P/Share
|
|
May 16
2022
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
55,321
-10.11%
|
$719,173
$13.64 P/Share
|
|
May 16
2022
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
5,000
-14.46%
|
$65,000
$13.62 P/Share
|
|
May 13
2022
|
David N Gill Director |
SELL
Open market or private sale
|
Direct |
5,313
-13.32%
|
$69,069
$13.1 P/Share
|
|
Mar 28
2022
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
6,104
-1.1%
|
$67,144
$11.62 P/Share
|
|
Mar 08
2022
|
Lauren P Silvernail Officer |
SELL
Open market or private sale
|
Direct |
10,192
-4.63%
|
$91,728
$9.73 P/Share
|
|
Mar 08
2022
|
Rui Avelar Officer |
SELL
Open market or private sale
|
Direct |
10,192
-3.87%
|
$91,728
$9.73 P/Share
|
|
Mar 08
2022
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
37,972
-6.42%
|
$341,748
$9.73 P/Share
|
|
Mar 08
2022
|
Crystal Muilenburg Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
6,495
-4.61%
|
$58,455
$9.73 P/Share
|
|
Jan 24
2022
|
Simone Blank Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+30.86%
|
-
|
|
Jan 24
2022
|
Robert Hayman Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+30.86%
|
-
|
|
Jan 24
2022
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+30.86%
|
-
|
|
Jan 24
2022
|
David N Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+28.08%
|
-
|
|
Jan 24
2022
|
Karah Herdman Parschauer Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+30.86%
|
-
|
|
Jan 24
2022
|
Vikram Malik Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,568
+18.35%
|
-
|
|
Jan 24
2022
|
Crystal Muilenburg Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+26.21%
|
-
|
|
Jan 24
2022
|
Rui Avelar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,571
+16.9%
|
-
|
|
Jan 24
2022
|
Lauren P Silvernail Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,571
+19.58%
|
-
|
|
Jan 24
2022
|
David Moatazedi Director |
BUY
Grant, award, or other acquisition
|
Direct |
214,286
+26.6%
|
-
|
|
Jan 05
2022
|
Brady Stewart Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,508
+50.0%
|
-
|
|
Sep 02
2021
|
Alphaeon 1 LLC |
SELL
Open market or private sale
|
Direct |
2,597,475
-29.99%
|
$23,377,275
$9.5 P/Share
|
|
Aug 27
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
51,000
+0.68%
|
$510,000
$10.93 P/Share
|
|
Aug 26
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
66,000
+0.88%
|
$726,000
$11.02 P/Share
|
|
Aug 25
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
44,000
+0.6%
|
$484,000
$11.12 P/Share
|
|
Aug 24
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
72,219
+0.98%
|
$794,409
$11.17 P/Share
|
|
Aug 23
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
69,781
+0.96%
|
$767,591
$11.03 P/Share
|
|
Aug 23
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
26,077
-2.23%
|
$286,847
$11.0 P/Share
|
|
Aug 20
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
48,000
+0.67%
|
$480,000
$10.56 P/Share
|
|
Aug 20
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
49,878
-4.09%
|
$498,780
$10.61 P/Share
|
|
Aug 19
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
55,000
+0.77%
|
$550,000
$10.51 P/Share
|
|
Aug 19
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
11,962
-0.97%
|
$119,620
$10.5 P/Share
|
|
Aug 18
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
45,000
+0.63%
|
$450,000
$10.54 P/Share
|
|
Aug 18
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
25,000
-1.99%
|
$250,000
$10.44 P/Share
|
|
Aug 17
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
70,000
+0.99%
|
$700,000
$10.69 P/Share
|
|
Aug 17
2021
|
Vikram Malik Director |
SELL
Open market or private sale
|
Indirect |
42,083
-3.24%
|
$420,830
$10.06 P/Share
|
|
Aug 16
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
65,000
+0.93%
|
$715,000
$11.34 P/Share
|
|
Aug 16
2021
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
47,737
-11.24%
|
$525,107
$11.35 P/Share
|
|
Aug 13
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Indirect |
14,043
+0.19%
|
$154,473
$11.11 P/Share
|
|
Aug 13
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
49,714
+0.72%
|
$497,140
$10.98 P/Share
|
|
Aug 13
2021
|
David Moatazedi Director |
SELL
Open market or private sale
|
Direct |
22,708
-5.07%
|
$227,080
$10.66 P/Share
|
|
Aug 12
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Indirect |
23,000
+0.31%
|
$230,000
$10.99 P/Share
|
|
Aug 12
2021
|
Medytox Inc. |
BUY
Open market or private purchase
|
Direct |
39,126
+0.57%
|
$391,260
$10.93 P/Share
|